apo-t.nl

Home

Preserving quality of life. Our goal is to deliver best-in-class therapeutic molecules for specific and sustainable treatment of cancer. APO-T is a privately owned biopharmaceutical company focusing on the development of new anti-cancer treatments. APO-T develops truly tumor-specific therapies. Present day treatments target tumor cells but also kill normal cells. This is why treatments result in devastating effects on quality of life. Sustainable Treatment of Cancer.

http://www.apo-t.nl/

OVERVIEW OF apo-t.nl

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

5

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR APO-T.NL

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 14 reviews

5 star

9

4 star

2

3 star

2

2 star

0

1 star

1

Hey there! Start your review of apo-t.nl

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.9 seconds

CONTACTS AT APO-T.NL

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

5

SSL

EXTERNAL LINKS

4

SITE IP

46.30.212.212

LOAD TIME

1.856 sec

SCORE

6.2

PAGE TITLE

Home | apo-t.nl Reviews

<META> DESCRIPTION

Preserving quality of life. Our goal is to deliver best-in-class therapeutic molecules for specific and sustainable treatment of cancer. APO-T is a privately owned biopharmaceutical company focusing on the development of new anti-cancer treatments. APO-T develops truly tumor-specific therapies. Present day treatments target tumor cells but also kill normal cells. This is why treatments result in devastating effects on quality of life. Sustainable Treatment of Cancer.

<META> KEYWORDS

1 technology and products

2 apoptosis inducing molecules

3 antibody drug conjugates

4 more details

5 mage

6 apoptosis

7 strategy

8 executive management

9 news

10 vacancies

CONTENT

Page content here

KEYWORDS ON PAGE

technology and products,apoptosis inducing molecules,antibody drug conjugates,more details,mage,apoptosis,strategy,executive management,news,vacancies,efficacious tumor therapy,apo t b v,executive board,utrechtseweg 223,the netherlands,info@apo t com

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home | apo-t.nl Reviews

https://apo-t.nl

Preserving quality of life. Our goal is to deliver best-in-class therapeutic molecules for specific and sustainable treatment of cancer. APO-T is a privately owned biopharmaceutical company focusing on the development of new anti-cancer treatments. APO-T develops truly tumor-specific therapies. Present day treatments target tumor cells but also kill normal cells. This is why treatments result in devastating effects on quality of life. Sustainable Treatment of Cancer.

INTERNAL PAGES

apo-t.nl

1

Executive Management

http://www.apo-t.nl/company/executive-management.html

Johan Renes, Msc Chief Executive Officer. Johan Renes (1962; Msc Molecular Biology) joined the management of APO-T at its inception. He has been an advisor to several life science companies (on Intellectual Property, Business Development and Management) from their inception in his capacity as a managing partner at an Intellectual Property Law Firm. Johan has been CEO of Crossbeta Biosciences in 2008-2010. He will devote his time to the overall strategy and general management of APO-T.

2

Vacancies

http://www.apo-t.nl/vacancies.html

At this moment we have no vacancies.

3

Company

http://www.apo-t.nl/company/index.html

Based in the Netherlands. APO-T was founded in 2011 by Dr. Ralph Willemsen (in Memoriam) and JPWaVe BV. Dr. Willemsen had been investigating tumor apoptosis at the Medical Centre of the Erasmus University Rotterdam, one of the largest academic hospitals in the world, for many years and has been focused on the development of the new cancer-specific therapeutic molecules currently in our portfolio since APO-T’s inception.

4

Home

http://www.apo-t.nl/index.html

Preserving quality of life. APO-T is a privately owned biopharmaceutical company focusing on the development of new anti-cancer treatments. Our mission is to serve patients with cancer by providing an efficacious specific treatment that preserves quality of life. Our programs are driven by their potential to replace and/or complement existing products which are associated with side effects and which allow tumors to escape therapy. APO-T develops truly tumor-specific therapies.

5

News

http://www.apo-t.nl/news.html

APO-T appoints Dr. Marta Kijanka as Vice-President of R&D. APO-T opens new laboratory and office facilities at PivotPark in Oss, the Netherlands, and expands its R&D staff. The Netherlands Enterprise Agency (RvO) grants APO-T an Innovation Credit for the development of its AIM therapy for the treatment of i.a. AML/MM. The credit consists of an investment of 1.5 million to support preclinical studies and a planned Phase I/II study. APO-T B.V. and LinXis B.V. both privately held oncology co...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

5

LINKS TO THIS WEBSITE

pivotpark.org

De ondernemingen - Life Sciences Community Oss

http://www.pivotpark.org/nl/44/de-ondernemingen

Ondernemers: een brede verscheidenheid. Pivot Park wordt gevormd door een brede verscheidenheid aan starters en reeds bestaande ondernemingen in de verschillende fases van geneesmiddelenontwikkeling:. Aduro Biotech Europe ontwikkelt, in samenwerking met top oncologiecentra in Nederland, antistoffen voor de behandeling van kanker. Het management heeft uitgebreide ervaring met laboratoriumonderzoek van antistoffen die immunologische afstoting van kanker stimuleren en de overlevingskans van kankerpatiën...

pivotpark.com

De ondernemingen - Life Sciences Community Oss

http://www.pivotpark.com/nl/44/de-ondernemingen

Ondernemers: een brede verscheidenheid. Pivot Park wordt gevormd door een brede verscheidenheid aan starters en reeds bestaande ondernemingen in de verschillende fases van geneesmiddelenontwikkeling:. Aduro Biotech Europe ontwikkelt, in samenwerking met top oncologiecentra in Nederland, antistoffen voor de behandeling van kanker. Het management heeft uitgebreide ervaring met laboratoriumonderzoek van antistoffen die immunologische afstoting van kanker stimuleren en de overlevingskans van kankerpatiën...

pivotpark.nl

De ondernemingen - Life Sciences Community Oss

http://www.pivotpark.nl/nl/44/de-ondernemingen

Ondernemers: een brede verscheidenheid. Pivot Park wordt gevormd door een brede verscheidenheid aan starters en reeds bestaande ondernemingen in de verschillende fases van geneesmiddelenontwikkeling:. Aduro Biotech Europe ontwikkelt, in samenwerking met top oncologiecentra in Nederland, antistoffen voor de behandeling van kanker. Het management heeft uitgebreide ervaring met laboratoriumonderzoek van antistoffen die immunologische afstoting van kanker stimuleren en de overlevingskans van kankerpatiën...

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

4

OTHER SITES

apo-sys.co.jp

A-システム｜薬局システムを安価で使いやすく!!

apo-sys.eu

u9334054.fsdata.se

Sidan är tills vidare avstängd. This page is closed until further notice.

apo-system.de

Neue Internetpräsenz

Hier entsteht eine neue Internetpräsenz!

apo-systeme.com

APO Hardware, Das Online-Portal für Apotheken Hardware, 24h-7Tage die Woche Online Bestellen

Mein Warenkorb: 0 Produkte. Hier gehts zur Anmeldung. Sie haben 0 Produkt(e) in Ihrem Warenkorb. Sie haben 0 Produkt(e) auf Ihrem Merkzettel. 24Std 7Tage Bestellen zu günstigen Konditionen. Wir stehen für Qualität. APO-Hardware.com wir sind für Apotheken da. TERRA PAD 1160 PRO i5-3337U W8P Point Multi-Touch Panel UMTS. Inkl 19% MwSt. zzgl. Versand. TERRA PAD 1160 PRO i5-3337U W8P Point Multi-Touch Panel UMTS. Ohne Tastatur, Tastatur ist seperat erhältich Artikel Nr: (tepata1160). Grafik dreno 305 (IGP), ...

apo-syutoken.com

薬剤師の転職・求人募集ナビ@首都圏・東京・横浜

調剤薬局すみれ薬局はごろも店東京都立川市羽衣町西国立駅より徒歩1分. 調剤薬局レジーナ薬局戸田店埼玉県戸田市氷川町 JR埼京線戸田駅徒歩20分. 調剤薬局薬局アボック川口幸町店埼玉県川口市幸町京浜東北線川口駅. 調剤薬局ムツミ薬局千葉県市原市 JR内房線姉ヶ崎駅徒歩3分. 調剤薬局森のくまさん薬局神奈川県相模原市 JR横浜線 JR相模線京王線橋本駅. 調剤薬局サンテ薬局西大泉店東京都練馬区西武池袋線保谷駅バス7分片山二丁. お問合せ、登録等は www.apoagent.jp.

apo-t.nl

Home

Preserving quality of life. Our goal is to deliver best-in-class therapeutic molecules for specific and sustainable treatment of cancer. APO-T is a privately owned biopharmaceutical company focusing on the development of new anti-cancer treatments. APO-T develops truly tumor-specific therapies. Present day treatments target tumor cells but also kill normal cells. This is why treatments result in devastating effects on quality of life. Sustainable Treatment of Cancer.

apo-take.biz

apo.take - Startseite

Unterschiede ( /-) im Sortiment aufgrund standort- oder kundenindividueller Besonderheiten sind möglich. Take part GmbH and Co. KG. Söflingerstraße 248 · 89077 Ulm. Telefon: 0731 - 8 40 85. Sie möchten apo.take kennenlernen? Sie möchten Presse-Infos/Medienberichte herunterladen? Sie wollen mehr über das Lizenzkonzept von apo.take erfahren?

apo-take.com

apo.take - Startseite

Unterschiede ( /-) im Sortiment aufgrund standort- oder kundenindividueller Besonderheiten sind möglich. Take part GmbH and Co. KG. Söflingerstraße 248 · 89077 Ulm. Telefon: 0731 - 8 40 85. Sie möchten apo.take kennenlernen? Sie möchten Presse-Infos/Medienberichte herunterladen? Sie wollen mehr über das Lizenzkonzept von apo.take erfahren?

apo-take.de

apo.take - Startseite

Unterschiede ( /-) im Sortiment aufgrund standort- oder kundenindividueller Besonderheiten sind möglich. Take part GmbH and Co. KG. Söflingerstraße 248 · 89077 Ulm. Telefon: 0731 - 8 40 85. Sie möchten apo.take kennenlernen? Sie möchten Presse-Infos/Medienberichte herunterladen? Sie wollen mehr über das Lizenzkonzept von apo.take erfahren?

apo-take.eu

apo.take - Startseite

Unterschiede ( /-) im Sortiment aufgrund standort- oder kundenindividueller Besonderheiten sind möglich. Take part GmbH and Co. KG. Söflingerstraße 248 · 89077 Ulm. Telefon: 0821 - 42 08 98 23. Radio / TV / Print: Berichte und Werbebeispiele. Sie wollen mehr über das Lizenzkonzept von apo.take erfahren?

apo-take.info

apo.take - Startseite

Unterschiede ( /-) im Sortiment aufgrund standort- oder kundenindividueller Besonderheiten sind möglich. Take part GmbH and Co. KG. Söflingerstraße 248 · 89077 Ulm. Telefon: 0731 - 8 40 85. Sie möchten apo.take kennenlernen? Sie möchten Presse-Infos/Medienberichte herunterladen? Sie wollen mehr über das Lizenzkonzept von apo.take erfahren?